Syntellix Asia and Chunli agree far-reaching co-operation to introduce and market innovative “quantum leap in implantology” MAGNEZIX® medtech devices in China
• Milestone contract signed between leading Chinese orthopaedic medtech supplier and Singapore based Asian subsidiary and hub of German world-market and technology leader in the area of bioabsorbable metallic implants for use in orthopaedic and trauma surgery
<p>• Contract volume of more than 100 million euros
<p>• Significant patient benefit for millions of people targeted in China’s vast medical technology market with world’s biggest population of 1.5 billion people
<p>• According to international experts, MAGNEZIX® implants developed by Syntellix are “clinically superior”, a “quantum leap in implantology” and the “new gold standard”
<p>• German Innovation Award has recently confirmed Syntellix’ technology leadership and user orientation